相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study
J. Cui et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique
Steven C. Lin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
You Zhou et al.
JOURNAL OF HEPATOLOGY (2015)
I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease
Jin-Ho Park et al.
LIVER INTERNATIONAL (2015)
Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases
Ming-Feng Xia et al.
OBESITY (2015)
Pnpla3I148M Knockin Mice Accumulate PNPLA3 on Lipid Droplets and Develop Hepatic Steatosis
Eriks Smagris et al.
HEPATOLOGY (2015)
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
Jiayun Shen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
J. Shen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
Amit G. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function
Piero Pingitore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods
D. Festi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease
N. S. Patel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese
Xiaoming Li et al.
PLOS ONE (2013)
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
Salvatore Petta et al.
PLOS ONE (2013)
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease
A. Zarrinpar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
Z. Permutt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: The Shanghai Changfeng study
Xiaoming Li et al.
ATHEROSCLEROSIS (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
John Zhong Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method
Ming-Feng Xia et al.
OBESITY (2012)
Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Meta-Analysis of the Influence of I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) on the Susceptibility and Histological Severity of Nonalcoholic Fatty Liver Disease
Silvia Sookoian et al.
HEPATOLOGY (2011)
Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
Mahesh K. Basantani et al.
JOURNAL OF LIPID RESEARCH (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
Elizabeth K. Speliotes et al.
PLOS GENETICS (2011)
Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption
Jaime N. Davis et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design
Xin Gao et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease
Weiqin Chen et al.
HEPATOLOGY (2010)
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CONTROLLED ATTENUATION PARAMETER (CAP): A NOVEL VCTE™ GUIDED ULTRASONIC ATTENUATION MEASUREMENT FOR THE EVALUATION OF HEPATIC STEATOSIS: PRELIMINARY STUDY AND VALIDATION IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSES
Magali Sasso et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2010)
Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene
Konstantinos Kantartzis et al.
DIABETES (2009)
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
A. Kotronen et al.
DIABETOLOGIA (2009)
Heritability of Nonalcoholic Fatty Liver Disease
Jeffrey B. Schwimmer et al.
GASTROENTEROLOGY (2009)
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2009)
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity
Lovisa E. Johansson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Role of Leisure-Time Physical Activity in Nonalcoholic Fatty Liver Disease: A Population-Based Study
Shira Zelber-Sagi et al.
HEPATOLOGY (2008)
Non-alcoholic fatty liver disease: The mist gradually clears
Nimantha Mark Wilfred de Alwis et al.
JOURNAL OF HEPATOLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Review article:: non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery
R. J. J. De Ridder et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study
Shira Zelber-Sagil et al.
JOURNAL OF HEPATOLOGY (2007)
Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary
Geoffrey C. Farrell et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults
Chien-Hua Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
KGMM Alberti et al.
DIABETIC MEDICINE (2006)
分享论文
